These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 9892369)

  • 1. Influence of the dialysis membrane on outcome of ESRD patients.
    Hakim RM
    Am J Kidney Dis; 1998 Dec; 32(6 Suppl 4):S71-5. PubMed ID: 9892369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of cellulose, modified cellulose and synthetic membranes in the haemodialysis of patients with end-stage renal disease.
    MacLeod A; Daly C; Khan I; Vale L; Campbell M; Wallace S; Cody J; Donaldson C; Grant A
    Cochrane Database Syst Rev; 2001; (3):CD003234. PubMed ID: 11687058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of membrane composition and structure on solute removal and biocompatibility in hemodialysis.
    Clark WR; Hamburger RJ; Lysaght MJ
    Kidney Int; 1999 Dec; 56(6):2005-15. PubMed ID: 10594776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute renal failure: role of dialysis membrane biocompatibility.
    Pascual M; Swinford RD; Tolkoff-Rubin N
    Annu Rev Med; 1997; 48():467-76. PubMed ID: 9046977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of the dialysis membrane on mortality of chronic hemodialysis patients.
    Hakim RM; Held PJ; Stannard DC; Wolfe RA; Port FK; Daugirdas JT; Agodoa L
    Kidney Int; 1996 Aug; 50(2):566-70. PubMed ID: 8840287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biocompatibility of the dialysis membrane.
    Takemoto Y; Naganuma T; Yoshimura R
    Contrib Nephrol; 2011; 168():139-145. PubMed ID: 20938134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship of dialysis membrane and cause-specific mortality.
    Bloembergen WE; Hakim RM; Stannard DC; Held PJ; Wolfe RA; Agodoa LY; Port FK
    Am J Kidney Dis; 1999 Jan; 33(1):1-10. PubMed ID: 9915261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biocompatibility and functional performance of a polyethylene glycol acid-grafted cellulosic membrane for hemodialysis.
    Sirolli V; Di Stante S; Stuard S; Di Liberato L; Amoroso L; Cappelli P; Bonomini M
    Int J Artif Organs; 2000 Jun; 23(6):356-64. PubMed ID: 10919752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kidney Failure and ESRD in the Atherosclerosis Risk in Communities (ARIC) Study: Comparing Ascertainment of Treated and Untreated Kidney Failure in a Cohort Study.
    Rebholz CM; Coresh J; Ballew SH; McMahon B; Whelton SP; Selvin E; Grams ME
    Am J Kidney Dis; 2015 Aug; 66(2):231-9. PubMed ID: 25773483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative evaluation of oxidative and antioxidative capacity during high-flux hemodialysis using two different membranes.
    Schönermarck U; Dengler C; Ebeling F; Heydenreich M; Hillebrand GF; Samtleben W
    Clin Nephrol; 2006 Nov; 66(5):357-63. PubMed ID: 17140165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of bioincompatibility in dialysis morbidity and mortality.
    Lazarus JM; Owen WF
    Am J Kidney Dis; 1994 Dec; 24(6):1019-32. PubMed ID: 7985663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Duration of end-stage renal disease and kidney transplant outcome.
    Goldfarb-Rumyantzev A; Hurdle JF; Scandling J; Wang Z; Baird B; Barenbaum L; Cheung AK
    Nephrol Dial Transplant; 2005 Jan; 20(1):167-75. PubMed ID: 15546892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure of dialysis membranes and long-term clinical outcome.
    Bonomini V; Coli L; Scolari MP; Stefoni S
    Am J Nephrol; 1995; 15(6):455-62. PubMed ID: 8546165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemodiafiltration does not increase the risk for mortality in ESRD.
    Schiffl H
    Am J Kidney Dis; 2005 Jul; 46(1):167-8; author reply 168-9. PubMed ID: 15983973
    [No Abstract]   [Full Text] [Related]  

  • 15. Platelet-neutrophil interactions during hemodialysis: a proposed biocompatibility approach.
    Stuard S; Bonomini M; Settefrati N; Albertazzi A
    Int J Artif Organs; 1998 Feb; 21(2):75-82. PubMed ID: 9569128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biocompatibility of PMMA membranes in acute and chronic patients with renal failure.
    Manzoni C; Locatelli F
    Contrib Nephrol; 1999; 125():65-75. PubMed ID: 9895431
    [No Abstract]   [Full Text] [Related]  

  • 17. Biocompatibility and permeability of dialyzer membranes do not affect anemia, erythropoietin dosage or mortality in japanese patients on chronic non-reuse hemodialysis: a prospective cohort study from the J-DOPPS II study.
    Yokoyama H; Kawaguchi T; Wada T; Takahashi Y; Higashi T; Yamazaki S; Fukuhara S; Akiba T; Akizawa T; Asano Y; Kurokawa K; Saito A;
    Nephron Clin Pract; 2008; 109(2):c100-8. PubMed ID: 18596379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biocompatibility and the clinical choice of dialysis membranes.
    Mujais SK; Ivanovich P; Bereza LA; Vidovich M
    Contrib Nephrol; 1995; 113():101-9. PubMed ID: 7712716
    [No Abstract]   [Full Text] [Related]  

  • 19. Biocompatible dialysis membranes and acute renal failure: a study in post-operative acute tubular necrosis in cadaveric renal transplant recipients.
    Valeri A; Radhakrishnan J; Ryan R; Powell D
    Clin Nephrol; 1996 Dec; 46(6):402-9. PubMed ID: 8982557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biocompatibility of dialysis membrane.
    Kes P
    Acta Med Croatica; 1999; 53(1):29-40. PubMed ID: 10437275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.